Manelimab
Manelimab is a monoclonal antibody that inhibits programmed death-ligand 1 (PD-L1) [1].
Product Specifications
CAS Number
2168561-26-8
Product Name Alternative
BCD-135
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/manelimab.html
Solubility
10 mM in DMSO
Smiles
[Manelimab]
References & Citations
[1]Aleksey Vladimirovich KONONOV, et al. Immunocytokine for activating human il-10ra receptor and use thereof. WO2022/124950 Al.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1075684-01 0.02 mg (E-Coli)
Recombinant Corynebacterium glutamicum UPF0176 protein cgR_2881 (cgR_2881)
Sign In for Pricing
View Details MBS1075684-02 0.02 mg (Yeast)
Recombinant Corynebacterium glutamicum UPF0176 protein cgR_2881 (cgR_2881)
Sign In for Pricing
View Details MBS1075684-03 0.1 mg (E-Coli)
Recombinant Corynebacterium glutamicum UPF0176 protein cgR_2881 (cgR_2881)
Sign In for Pricing
View Details MBS1075684-04 0.1 mg (Yeast)
Recombinant Corynebacterium glutamicum UPF0176 protein cgR_2881 (cgR_2881)
Sign In for Pricing
View Details MBS1075684-05 0.02 mg (Baculovirus)
Recombinant Corynebacterium glutamicum UPF0176 protein cgR_2881 (cgR_2881)
Sign In for Pricing
View Details